Influence of Concurrent Capecitabine Based Chemoradiotherapy with Bevacizumab on The Survival Rate, Late Toxicity and Health-related Quality of Life in Locally Advanced Rectal Cancer: a Prospective Phase II CRAB Trial

Lignende værker

• The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection
  af: Grosek, Jan, et al.
  Udgivet: (2016)
• Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
  af: Velenik, Vaneja, et al.
  Udgivet: (2011)
• Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
  af: Tuta, Mojca, et al.
  Udgivet: (2019)
• Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
  af: Tuta, Mojca, et al.
  Udgivet: (2021)
• Induction Chemotherapy, Chemoradiotherapy and Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer - Long-term Results of Phase II OIGIT-01 Trial
  af: Golo, Danijela, et al.
  Udgivet: (2018)